AUDRA FEGLEY: Open Payments
NPI 1932340361 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 34 payments from 10 companies in 2025. Trend: 2023 $1,396 · 2024 $1,450 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $117 |
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| Janssen Pharmaceuticals, Inc | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Corium, LLC | 2 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Qelbree, CAPLYTA, FANAPT, SPRAVATO, AUSTEDO XR, Azstarys, INGREZZA, ARISTADA.
Industry payments across TN — which companies pay providers there.
